Immunome Inc expected to post a loss of 76 cents a share - Earnings Preview

Immunome

11/11/2022 12:05

* Immunome Inc  IMNM.OQ   IMNM.O  is expected to show no
change in
quarterly revenue when it reports  results on November 14
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Immunome Inc is for
a
loss of 76 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunome
Inc is
$8.5​, above​ its last closing price of $4.10. ​​​

This summary was machine generated November 11 at 12:05 GMT. 
All figures in US dollars  unless otherwise stated